Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Gland Pharma Ltd. ( (IN:GLAND) ) has issued an announcement.
Gland Pharma Limited has announced the appointment of M/s. RVR & Associates as the Secretarial Auditors for a term of five years, following approval at the company’s 47th Annual General Meeting. This strategic appointment is expected to enhance the company’s compliance management and corporate governance, potentially strengthening its market position and stakeholder confidence.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its robust portfolio of products and its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 8,931
Technical Sentiment Signal: Buy
Current Market Cap: 317.7B INR
Find detailed analytics on GLAND stock on TipRanks’ Stock Analysis page.